Healthcare

Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

Beginning October 1, American citizens who do not have health insurance will be eligible to purchase standardized insurance coverage using the new health insurance marketplaces, formally referred to as health insurance exchanges (HIX). This offering will be administered either by their state, federal government, or a combination of both. CMS has re...

Digital health is an important area, which is expected to positively drive healthcare transformation and change the experience of all stakeholders in how they interact with technology and engage each other. This market insight presents some interesting points observed at the Digital Health Summer Summit, including the BlueStar announcement from We...

This market insight is an attempt to analyse the market dynamics and trends in patient safety, and the use of healthcare IT solutions as an enabler for patient safety enhancement. The study covers in detail the patient safety scenario in Europe, EU commission's activity in area of patient safety, and specific details centring on UK, Denmark, and Fr...

This research service provides insight into the top therapeutics sold at a Kenyan private outpatient pharmacy, located in one of Nairobis largest private hospitals. This service gives a brief overview of the healthcare structure in Kenya. Key therapeutic segments analyzed include anti-infectives, cardiovascular, and diabetes therapeutic segments. S...

The 2014 rollout of the federal health insurance exchange (HIX) market is set to define some new limits for intrastate and interstate information transparency across insurance providers. Stemming from the Patient Protection and Affordable Care Act (PPACA), the mandate for competitive insurance platforms are possibly the largest and most controversi...

The following market insight discusses Frost & Sullivan telehealth perspectives post ATA 2013. This includes observations and perspectives from the conference, topline survey findings on different issues in telehealth run by Frost & Sullivan, and other national trends centric to the industry.

This issue of Vital Signs published June 30, 2013, provides a global overview of market trends and expected growth of the Point-of-care Testing (POCT) market.

This issue of Vital Signs, released on June 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.